WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Gilmore Neil OneillCEO2024-03-0577,824$9.42
$732.87kSell
Baisong MeiSVP CHIEF MEDICAL OFFICER2024-03-0420,327$9.42
$191.42kSell
Bruce EatonEVP CBO AND CTO2023-12-05103$10.90
$1.12kSell
Bruce EatonEVP CBO AND CTO2023-11-14695$8.21
$5.71kSell
Bruce EatonEVP CBO AND CTO2023-11-07139$8.40
$1.17kSell
Bruce EatonEVP CBO AND CTO2023-09-06103$8.82
$908.46Sell
Bruce EatonEVP CBO AND CTO2023-08-11702$8.59
$6.03kSell
Bruce EatonEVP CBO AND CTO2023-08-08141$8.39
$1.18kSell
Baisong MeiSVP CHIEF MEDICAL OFFICER2023-07-194,317$8.80
$37.99kSell
Gilmore Neil OneillCEO2023-06-056,486$9.50
$61.64kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.34%8,461,857$45.27MInstitution
Blackrock Inc9.58%7,838,969$41.94MInstitution
Deep Track Capital LP6.69%5,473,086$29.28MInstitution
State Street Corp6.20%5,069,543$27.12MInstitution
Third Rock Ventures Iii LP4.77%3,906,176$20.90MInsider
Kevin P. Starr4.77%3,906,176$20.90MInsider
Polaris Venture Management Co Vi LLC4.64%3,797,144$20.31MInsider
Viking Global Investors LP3.66%2,996,590$16.03MInsider
Kevin Bitterman3.42%2,797,144$14.96MInsider
Flagship Ventures Fund Iv LP3.41%2,786,967$14.91MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT64.04%35.96%Net SellingNet Selling
CCCC68.39%25.32%Net BuyingNet Selling
THRD73.29%26.71%Net BuyingNet Buying
TSHA69.58%15.93%Net BuyingNet Selling
SLRN73.07%26.93%Net BuyingNet Selling

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 71.84% institutional shareholders, 40.34% Editas Medicine insiders, and 0.00% retail investors. Third Rock Ventures Iii LP is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 4.77% of the company. Third Rock Ventures Iii LP's Editas Medicine shares are currently valued at $20.39M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.